| scholarly article | Q13442814 |
| P50 | author | Charles A. Dinarello | Q834442 |
| Mihai Netea | Q24517868 | ||
| P2093 | author name string | Adriana Weinberg | |
| Mihai G. Netea | |||
| Leonid L. Reznikov | |||
| Michael A. Zimmerman | |||
| Frederick L. Grover | |||
| Craig H. Selzman | |||
| P2860 | cites work | Therapeutic implications of inflammation in atherosclerotic cardiovascular disease | Q34293729 |
| Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells | Q35488540 | ||
| Interleukin-18 (IFNgamma-inducing factor) induces IL-8 and IL-1beta via TNFalpha production from non-CD14+ human blood mononuclear cells | Q37378111 | ||
| Randomized secondary prevention trial of azithromycin in patients with coronary artery disease: primary clinical results of the ACADEMIC study | Q37875542 | ||
| Chlamydia pneumoniae activates nuclear factor kappaB and activator protein 1 in human vascular smooth muscle and induces cellular proliferation | Q37876664 | ||
| Acellular components of Chlamydia pneumoniae stimulate cytokine production in human blood mononuclear cells | Q37877073 | ||
| Chlamydia pneumoniae infection of vascular smooth muscle and endothelial cells activates NF-kappaB and induces tissue factor and PAI-1 expression: a potential link to accelerated arteriosclerosis | Q37877720 | ||
| Chlamydia pneumoniae infection of human endothelial cells induces proliferation of smooth muscle cells via an endothelial cell-derived soluble factor(s). | Q37878378 | ||
| Antibiotics and risk of subsequent first-time acute myocardial infarction | Q37879181 | ||
| Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model | Q37881464 | ||
| Chronic Chlamydia pneumoniae infection is associated with a serum lipid profile known to be a risk factor for atherosclerosis | Q37881850 | ||
| Chronic infections and coronary heart disease: is there a link? | Q37882245 | ||
| Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS Pilot Study. ROXIS Study Group | Q37882250 | ||
| Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction | Q37882420 | ||
| Growth of Chlamydia pneumoniae in cultured human peripheral blood mononuclear cells and induction of a cytokine response | Q37884521 | ||
| Use of HEp-2 cells for improved isolation and passage of Chlamydia pneumoniae | Q37892713 | ||
| Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction | Q37899465 | ||
| The p53 network | Q41673584 | ||
| Interleukin-8. A mitogen and chemoattractant for vascular smooth muscle cells | Q72018966 | ||
| Interleukin-10 inhibits human vascular smooth muscle proliferation | Q74591618 | ||
| Class II cytokine receptor ligands inhibit human vascular smooth muscle proliferation | Q77098119 | ||
| Liposomal delivery of purified inhibitory-kappaBalpha inhibits tumor necrosis factor-alpha-induced human vascular smooth muscle proliferation | Q77381378 | ||
| The NFkappaB inhibitory peptide, IkappaBalpha, prevents human vascular smooth muscle proliferation | Q77833086 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | surgery | Q40821 |
| atherosclerosis | Q12252367 | ||
| Chlamydia pneumoniae | Q62869737 | ||
| Cardiology and cardiovascular medicine | Q96320350 | ||
| P1104 | number of pages | 6 | |
| P304 | page(s) | 688-693 | |
| P577 | publication date | 2003-09-01 | |
| P1433 | published in | The Journal of Thoracic and Cardiovascular Surgery | Q2795598 |
| P1476 | title | Atherogenic effects of Chlamydia pneumoniae: refuting the innocent bystander hypothesis | |
| Atherogenic effects of chlamydia pneumoniae: refuting the innocent bystander hypothesis | |||
| P478 | volume | 126 |
Search more.